about
Fluid Resuscitation in SepsisTroponin T level and mortality risk after noncardiac surgery: practical implications of the VISION study.Varicose veins of lower extremities, hemodynamics and treatment methods.Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphismLipoxins and aspirin-triggered lipoxins in airway responsesFunctional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma[Thrombotic thrombocytopenic purpura -- a rare complication associated with clopidogrel therapy. A case report].[Thrombotic thrombocytopenic purpura with myocardial ischaemia: two case reports].The impact of weather factors, moon phases, and seasons on abdominal aortic aneurysm rupture.Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery.Cardiac involvement in Wegener's granulomatosis resistant to induction therapy.Prognostic capabilities of coronary computed tomographic angiography before non-cardiac surgery: prospective cohort study.Association between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study.Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegener's) in patients with normal electrocardiograms and transthoracic echocardiographyThe impact of current health-related quality of life on future health outlook in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener's) patients.Urinary 11-Dehydro-Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) StudyCutting edge issues in the Churg-Strauss syndrome.The coronary CT angiography vision protocol: a prospective observational imaging cohort study in patients undergoing non-cardiac surgery.Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management.Continuous renal replacement therapy during extracorporeal membrane oxygenation in patients treated in medical intensive care unit: technical considerations.Modern methods for endoscopic treatment of obstructive pulmonary diseases.IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: systematic review of its prevalence in chronic hepatitis C patients and general population frequency.Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis.Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.Corticosteroids in sepsis: an updated systematic review and meta-analysis (protocol).12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg-Strauss syndrome.Myocardial Injury After Noncardiac Surgery (MINS) in Vascular Surgical Patients: A Prospective Observational Cohort Study.Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery.Bleeding impacting mortality after noncardiac surgery: a protocol to establish diagnostic criteria, estimate prognostic importance, and develop and validate a prediction guide in an international prospective cohort study.[The influence of leukotriene receptor antagonists treatment on Churg-Strauss syndrome].Influence of leukotriene biosynthesis inhibition on heart rate in patients with atrial fibrillation.Supportive therapy for a patient with toxic epidermal necrolysis undergoing plasmapheresis.Effect of delayed diagnosis on disease course and management of Churg-Strauss syndrome: a retrospective study.Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4).[Recurrent crural phlegmonous abscesses as a sign of Münchausen syndrome in a young woman].Aspirin tolerance and leukotriene biosynthesis in Churg-Strauss syndrome.Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study.Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes.Chloride and Other Electrolyte Concentrations in Commonly Available 5% Albumin Products.
P50
Q22305304-1EBE9A9D-108C-4498-8BAD-C8FC0C58895CQ27687526-811452FB-C502-4E4E-A2ED-3B4A690F498AQ27691320-01CBC724-CE87-4240-9153-B6B54B3D09C8Q28191711-CFEAF0C0-0A9B-42F3-8E5F-9925705A2A90Q28196111-F3D47DF4-BCDF-42D9-812C-C529BB278133Q28211158-FCFE4D6F-3961-4D1F-AEFD-333A0BFB8FCCQ33369156-9380E128-826C-478F-98A9-FA61321EBF46Q33381630-0AAEEF97-353F-4D94-B25E-9C0F77A40E8DQ33460353-A6DFBA61-0200-4685-92A8-7CAF6AF5CC7CQ34282230-5FD7F315-6127-4A98-89D9-454D74480382Q35250782-E6CB7BCA-E8BD-4B01-AD58-8BB91D0A4A1AQ35550873-D9A32792-27B8-4914-BAA3-D700ADDCE851Q36438192-98296CD8-74BC-4C5D-9559-AF39D5FFAF83Q36816527-93FE11E9-3BA6-453B-BFD0-6D1929A517A5Q36927595-07E4764B-C6DC-4D17-8F7E-A187F734FB39Q37185572-54B6A925-3D38-4F35-A947-EA070DC9658DQ37240415-3803EF60-E735-4B26-9D91-E5AF288D2C62Q37850388-101E91D5-BF81-42CF-926A-538A9ADE710EQ38031459-79C0D919-4E2F-4396-A3CD-1C60BF602EA6Q38164506-AB0230DA-2DF8-4147-80CA-BEB642D18DB2Q38246655-7E95F7B0-4DBE-4DCE-A649-2D25F4CB0C28Q38315757-BB82E1FF-981C-491B-93A2-148BB297A1C6Q38364943-B3DF21C5-D710-4E4A-8F04-928A47C9C174Q38436829-8DB2E713-4658-4198-83CA-83DFDDE2C73EQ38752767-ECA21DA8-B7FA-4E85-98C3-CE94043B50A2Q39408165-49947A7D-43AD-4C0A-9643-15EDA0CC94A4Q39640988-06EFE396-7F86-4A5E-9464-DAA432532F00Q40209046-360357DA-CDC9-47CC-A79A-CE8358A001BDQ40227487-58E2E31C-7762-4A53-A192-555955CC37EEQ42692713-FAF22512-5219-4A15-930E-AD7B83FC0F21Q42746745-030683E3-EF85-4BCA-995E-FF5D337A5511Q42862197-88C6A309-8E14-4D17-B3D0-FC77AAF0A671Q43660627-BFF98704-81AC-4D1A-B039-F849B5C974F4Q43776735-8C4C25F4-E9BD-4523-870A-C775DC484C78Q44097824-09D54CF8-FE24-4D80-9AEF-43B7F390FCAEQ44329136-1822C7B3-27C2-46EE-B22E-914B30295A3FQ46512064-76B1CFEA-0CBA-4A52-9009-6313418A0FA5Q46948868-2C66FE9E-A55B-4BE9-A76F-B9DEC77AE9B1Q46960763-A49B3742-9884-43A6-878A-09C23C17B395Q47182198-30043258-3F5F-41F9-ABB5-7B96BFC87045
P50
description
Polish physician
@en
Pools onderzoeker
@nl
dochtúir Polannach
@ga
polski lekarz
@pl
name
Wojciech Szczeklik
@ast
Wojciech Szczeklik
@ca
Wojciech Szczeklik
@cs
Wojciech Szczeklik
@en
Wojciech Szczeklik
@es
Wojciech Szczeklik
@ga
Wojciech Szczeklik
@gl
Wojciech Szczeklik
@hr
Wojciech Szczeklik
@hsb
Wojciech Szczeklik
@it
type
label
Wojciech Szczeklik
@ast
Wojciech Szczeklik
@ca
Wojciech Szczeklik
@cs
Wojciech Szczeklik
@en
Wojciech Szczeklik
@es
Wojciech Szczeklik
@ga
Wojciech Szczeklik
@gl
Wojciech Szczeklik
@hr
Wojciech Szczeklik
@hsb
Wojciech Szczeklik
@it
prefLabel
Wojciech Szczeklik
@ast
Wojciech Szczeklik
@ca
Wojciech Szczeklik
@cs
Wojciech Szczeklik
@en
Wojciech Szczeklik
@es
Wojciech Szczeklik
@ga
Wojciech Szczeklik
@gl
Wojciech Szczeklik
@hr
Wojciech Szczeklik
@hsb
Wojciech Szczeklik
@it
P214
P106
P1153
6602352534
P1412
P1559
Wojciech Szczeklik
@pl
P21
P214
P27
P31
P3124
P496
0000-0002-1349-1123
P734
P735
P7859
viaf-311805908